SCHEMBL3855293

SCHEMBL3855293

CCC1c2cc(F)ccc2-c2ccccc2N1C(=O)c1ccc(OC)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 2/20 0.45
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GAA P10253 2/20 0.40
POLB P06746 1/20 0.40
TP53 P04637 1/20 0.40
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
HSD11B1 P28845 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3863525 0.88 KMT2A (0.41) P2RY1MEN1KMT2APOLB
SCHEMBL3855401 0.88 KMT2A (0.41) P2RY1MEN1KMT2APOLB
SCHEMBL3860306 0.87 CPS1 (0.45) TP53
SCHEMBL3856380 0.86 RAB9A (0.43) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL3854734 0.86 ALDH1A1 (0.46) P2RY1ALDH1A1SMN1; SMN2NPC1HPGD
SCHEMBL3860975 0.82 KMT2A (0.39) ALDH1A1SMN1; SMN2HPGDNPSR1MEN1
SCHEMBL3855301 0.80 GAA (0.44) P2RY1ALDH1A1SMN1; SMN2NPC1HPGD
SCHEMBL3855280 0.78 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL5211455 0.77 PSEN1 (0.47) ALDH1A1SMN1; SMN2NPC1NPSR1LMNA
SCHEMBL3854163 0.77 PDK1 (0.38) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585871-B2 4-{[(6R)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 3-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 4-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; cytokine expression WYETH (US) 2009-09-08 US disclosed
EP-1784391-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE EXPRESSION MODULATORS Wyeth (US) 2007-05-16 EP disclosed
US-20060058337-A1 Phenanthridine carbonyl phenols WYETH (US) 2006-03-16 US disclosed
WO-2006028875-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE MODULATORS WYETH (US) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058337-A1 Phenanthridine carbonyl phenols MT-CO2, PAH, CBR3 P2RY1 4188/4885ALDH1A1 985/4885SMN1; SMN2 4530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.